These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7131755)

  • 21. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory and clinical studies on cefoxitin in the field of obstetrics and gynecology (author's transl)].
    Hirabayashi K; Okada E
    Jpn J Antibiot; 1978 Jun; 31(6):315-24. PubMed ID: 355681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of cefoxitin in children (author's transl)].
    Meguro H; Mashiko J; Matsueda Y; Ohnari S; Hashimoto G; Fujii R
    Jpn J Antibiot; 1981 Mar; 34(3):237-43. PubMed ID: 7289018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the in vitro activity of cefoxitin and cephalothin against 7,312 clinical isolates.
    Lingaas E; Midtvedt T; Melby K; Dahl OU
    Chemotherapy; 1981; 27(4):239-46. PubMed ID: 7249786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of cefoxitin in the treatment of severe infections in patients with hematopoietic disorders].
    Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Tsubakio T; Kawagoe H; Shinohara Y; Nasu T
    Jpn J Antibiot; 1982 May; 35(5):1212-22. PubMed ID: 6752459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical experience with cefoxitin in pediatric field (author's transl)].
    Okamoto T; Ohara K; Tomimatsu H; Hosoda T
    Jpn J Antibiot; 1981 Mar; 34(3):352-8. PubMed ID: 7289027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined action of cephamycin and aminoglycoside antibiotics].
    Tanaka M; Kawabata S; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Oct; 36(10):2869-80. PubMed ID: 6674522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The choice of antibiotics for prophylaxis of postoperative infections in the field of orthopaedics. Clinical experience with cefoxitin].
    Doi K; Kawai S; Imagama T; Oda H; Oka S; Sunago K; Saika M
    Jpn J Antibiot; 1985 Jan; 38(1):83-94. PubMed ID: 3989982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical studies of cefoxitin in the field of internal medicine].
    Ito A; Shindo K; Sakamoto H; Sano F; Ishigatsubo Y; Matsumura M; Tani K; Maruta I; Kodama F; Fukushima K
    Jpn J Antibiot; 1983 Jan; 36(1):84-92. PubMed ID: 6842829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical use of cefoxitin in respiratory tract infections].
    Niki Y; Yoshida N; Hara H; Soejima R
    Jpn J Antibiot; 1984 Jan; 37(1):97-103. PubMed ID: 6727034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical trial of cefoxitin used in the treatment of patients with cholesteatoma undergoing surgical procedures].
    Morikawa K
    Jpn J Antibiot; 1982 Dec; 35(12):2761-7. PubMed ID: 7182531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical studies on cefoxitin in the treatment of respiratory tract infections].
    Kuwabara M; Kodomari Y; Jyo T; Kuraoka T; Mitsuyama T; Kodomari N; Iwamoto K; Miyazawa T; Watanabe T; Morikawa E
    Jpn J Antibiot; 1984 Sep; 37(9):1685-93. PubMed ID: 6512985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative evaluation of the safety and efficacy of cefotetan and cefoxitin in surgical prophylaxis.
    Shwed JA; Danziger LH; Wojtynek J; Rodvold KA
    DICP; 1991 Jan; 25(1):10-3. PubMed ID: 2008777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibacterial activity of cefoperazone against anaerobic bacteria (author's transl)].
    Imamura H; Kobayashi T; Murata K; Kohbata S; Watanabe I; Marui T; Watanabe K; Ninomiya K; Ueno K; Suzuki S
    Jpn J Antibiot; 1980 Nov; 33(11):1171-82. PubMed ID: 6454011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical studies of cefoxitin with special reference to pulmonary suppuration and pyothorax with respiratory tract infection].
    Ito T
    Jpn J Antibiot; 1984 Sep; 37(9):1679-84. PubMed ID: 6512984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Laboratory and clinical studies on cefoxitin in pediatric field (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Osuga T; Inokuma K
    Jpn J Antibiot; 1981 Mar; 34(3):287-304. PubMed ID: 7289022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fundamental and clinica evaluation of cefoxitin in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Ookura K; Kuroki S; Murakami M; Tomizawa T; Kikawa Y; Kasei M; Hayashi R
    Jpn J Antibiot; 1981 Mar; 34(3):318-32. PubMed ID: 7289025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of cefotaxime for postoperative infection in surgery].
    Nakanishi Y; Kasai Y; Maeda A; Hasegawa N; Hasegawa M; Gotoh Y; Higa T; Takamura M; Yagi Y; Nakamura T
    Jpn J Antibiot; 1984 Sep; 37(9):1729-50. PubMed ID: 6096587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.